These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2062152)

  • 1. In search of missing links in otology. II. Development of an implantable middle ear drug delivery system: initial studies of sustained ampicillin release for the treatment of otitis media.
    Goycoolea MV; Muchow DC; Sirvio LM; Winandy RM
    Laryngoscope; 1991 Jul; 101(7 Pt 1):727-32. PubMed ID: 2062152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of antimicrobials in the middle ear using a biodegradable support.
    Goycoolea MV; Muchow DC
    Ann Otol Rhinol Laryngol Suppl; 1994 May; 163():46-8. PubMed ID: 8179270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended middle ear drug delivery. A new concept; a new device.
    Goycoolea MV; Muchow DD; Sirvio LM; Winandy RM; Canafax DM; Hueb M
    Acta Otolaryngol Suppl; 1992; 493():119-26. PubMed ID: 1636411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of the efficacy of ampicillin in the treatment of pneumococcal otitis media in a chinchilla animal model.
    Supance JS; Marshak G; Doyle WJ; Cantekin EI
    Ann Otol Rhinol Laryngol; 1982; 91(3 Pt 1):256-60. PubMed ID: 7201289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTO-201: nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media.
    Wang X; Fernandez R; Tsivkovskaia N; Harrop-Jones A; Hou HJ; Dellamary L; Dolan DF; Altschuler RA; LeBel C; Piu F
    Otol Neurotol; 2014 Mar; 35(3):459-69. PubMed ID: 24518407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 receptor antagonist as an adjunct in the treatment of Haemophilus influenzae otitis media in the chinchilla.
    Kerschner JE; Beste DJ; Lynch JB; Fox MC; Kehl KS
    Laryngoscope; 2000 Sep; 110(9):1457-61. PubMed ID: 10983942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle-ear effusions following acute otitis media in the chinchilla animal model.
    Mills R; Gilsdorf J
    J Laryngol Otol; 1986 Mar; 100(3):255-61. PubMed ID: 3485165
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained release of antibiotic from a fibrin-gelatin-antibiotic mixture.
    Park MS; Kim YB
    Laryngoscope; 1997 Oct; 107(10):1378-81. PubMed ID: 9331317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of ciprofloxacin and ceftriaxone from a single ototopical administration of antibiotic-loaded polymer microspheres and thermoresponsive gel.
    Bruk LA; Dunkelberger KE; Khampang P; Hong W; Sadagopan S; Alper CM; Fedorchak MV
    PLoS One; 2020; 15(10):e0240535. PubMed ID: 33045028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental acute otitis media with ibuprofen and ampicillin.
    Diven WF; Evans RW; Alper C; Burckart GJ; Jaffe R; Doyle WJ
    Int J Pediatr Otorhinolaryngol; 1995 Oct; 33(2):127-39. PubMed ID: 7499045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of concentration of ampicillin into middle ear effusion after administration of bacampicillin].
    Itabashi T; Kawamura S; Sugita R; Fujimaki Y; Deguchi K; Fukayama S; Yokota N; Tanaka S; Nishimura Y; Yoshihara H
    Jpn J Antibiot; 1986 Aug; 39(8):1975-80. PubMed ID: 3795476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ibuprofen treatment during experimental acute otitis media.
    Diven WF; Evans RW; Swarts JD; Burckart GJ; Doyle WJ
    Auris Nasus Larynx; 1995; 22(2):73-9. PubMed ID: 7487676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function.
    Hoffer ME; Allen K; Kopke RD; Weisskopf P; Gottshall K; Wester D
    Laryngoscope; 2001 Aug; 111(8):1343-57. PubMed ID: 11568567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle ear inflammatory mediators and cochlear function.
    Morizono T; Tono T
    Otolaryngol Clin North Am; 1991 Aug; 24(4):835-43. PubMed ID: 1870877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of otic suppositories containing ampicillin sodium in treating chronic suppurative mesotympanitis].
    Kal'shteĭn LI; Gorbunova AD; Pilosov AM; Umarov UU
    Zh Ushn Nos Gorl Bolezn; 1980; 1():64-6. PubMed ID: 7361527
    [No Abstract]   [Full Text] [Related]  

  • 18. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulbactam/ampicillin in the treatment of otitis and sinusitis.
    Nicoletti G; Speciale A; Caccamo F; Raso F
    J Int Med Res; 1991; 19 Suppl 1():29A-35A. PubMed ID: 2060691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence of bacterial biofilms in otitis media.
    Post JC
    Laryngoscope; 2001 Dec; 111(12):2083-94. PubMed ID: 11802002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.